| |
| |
|
| Insider
Information: |
Malik Fady Ibraham |
| Relationship: |
EVP Research & Develop... |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
135,004 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$7,280,766 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
135,004 |
|
|
| Total
Value |
$7,280,766 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
7
|
|
Stock
price went up :
|
0
|
5
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.5
|
| Percentage
Gain/Loss : |
0.0%
|
 322.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cytokinetics Inc |
CYTK |
EVP Research & Develop... |
2024-06-11 |
135,004 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
120 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2020-02-26 |
4 |
D |
$14.07 |
$100,157 |
D/D |
(7,121) |
114,229 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
SVP Research & Early Dev |
• – – |
2012-09-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
87,500 |
121,132 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2024-03-06 |
4 |
D |
$66.88 |
$542,330 |
D/D |
(8,109) |
121,234 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2019-12-05 |
4 |
AS |
$9.80 |
$14,700 |
D/D |
(1,500) |
121,350 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2019-10-03 |
4 |
AS |
$11.22 |
$16,830 |
D/D |
(1,500) |
122,067 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2019-11-07 |
4 |
AS |
$9.98 |
$14,970 |
D/D |
(1,500) |
122,850 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2019-09-05 |
4 |
AS |
$13.69 |
$20,531 |
D/D |
(1,500) |
123,567 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2019-08-08 |
4 |
AS |
$13.52 |
$20,280 |
D/D |
(1,500) |
125,067 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2019-07-11 |
4 |
S |
$11.26 |
$16,890 |
D/D |
(1,500) |
126,567 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2019-06-06 |
4 |
AS |
$10.31 |
$15,463 |
D/D |
(1,500) |
128,067 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2019-05-02 |
4 |
AS |
$8.29 |
$12,430 |
D/D |
(1,500) |
129,567 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2019-04-04 |
4 |
AS |
$8.31 |
$12,465 |
D/D |
(1,500) |
131,067 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2019-03-07 |
4 |
AS |
$5.98 |
$8,970 |
D/D |
(1,500) |
132,567 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2024-03-04 |
4 |
D |
$67.68 |
$651,758 |
D/D |
(9,630) |
133,343 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2019-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
134,067 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2024-06-11 |
4 |
S |
$53.03 |
$413,106 |
D/D |
(7,788) |
135,004 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2023-03-06 |
4 |
D |
$39.13 |
$194,007 |
D/D |
(4,958) |
135,183 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2024-05-07 |
4 |
AS |
$65.11 |
$1,012,265 |
D/D |
(15,547) |
137,056 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2024-04-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
150 |
138,417 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2024-04-09 |
4 |
S |
$74.31 |
$2,422,918 |
D/D |
(32,605) |
138,567 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2024-03-05 |
4 |
AS |
$67.53 |
$2,202,606 |
D/D |
(32,604) |
138,973 |
0 |
% |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2021-03-01 |
4 |
D |
$19.66 |
$54,399 |
D/D |
(2,767) |
138,982 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2023-03-02 |
4 |
D |
$39.60 |
$427,086 |
D/D |
(10,785) |
140,141 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• – – |
2021-02-26 |
4 |
D |
$18.73 |
$132,234 |
D/D |
(7,060) |
141,749 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
EVP Research & Development |
• • – |
2024-03-14 |
4 |
A |
$0.00 |
$0 |
D/D |
21,333 |
142,567 |
0 |
- |
|
120 Records found
|
|
Page 2 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
